MediView key facts
as of Oct 2026- Developer of an extended reality surgical navigation technology designed to maximize the accuracy and efficacy of cancer therapies.
- MediView is valued at approximately $93.5M as of Oct 2026 (last reported valuation).
- It has raised $43.9M; the latest was Later Stage VC ($14.0M) in Jan 2025.
- Notable investors include Plug and Play Tech Center, JobsOhio Ventures, Mayo Clinic Ventures, Echo Investment Capital, Edge Ventures — 16 tracked in total.
- Status: Privately Held (backing).
MediView's last reported valuation, Jan 2025. Nothing priced has surfaced since.
- ·The complete investor list: 16 names
- ·Watch MediView: the Monday email on marks, rounds and moves
MediView funding rounds
No funding rounds for MediView are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs MediView
16+MediView valuation
MediView's last reported valuation was $93.5 million in Jan 2025. No priced round, secondary trade or fund mark has surfaced since.
MediView investors
16 investors are on record for MediView, including Plug and Play Tech Center, JobsOhio Ventures, Mayo Clinic Ventures and Echo Investment Capital.
About MediView
Developer of an extended reality surgical navigation technology designed to maximize the accuracy and efficacy of cancer therapies. The company's technology involves real-time, fused-holographic visualization and facilitates surgical navigation and telehealth with augmented reality 3D (three-dimensional) visualization and remote collaboration, enabling healthcare providers to optimally examine a patient using a hologram instead of a conventional 2D (two-dimensional) display screen.
- Sector
- Healthcare
- HQ
- Cleveland, OH, United States
- Founded
- 2017
- Employees
- 44
- Website
- mediview.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.